Every optometry center and pediatric ophthalmology department shares the same daily challenge: too many young patients, too few specialists, and treatment plans that depend heavily on equipment that lives inside the clinic. Families miss sessions, therapy progress is hard to measure, and clinicians spend hours on repetitive follow-up. Guangzhou Shijing Medical Software Co., Ltd. was founded in 2008 to attack that problem from a different angle — by turning vision rehabilitation into a measurable, software-driven and location-flexible clinical service.
A Medical Technology Company Focused on Functional Eye Disease
Shijing Medical is a research-driven medical technology company working in ophthalmology and optometry. Its engineering focus sits at the intersection of three disciplines: artificial intelligence, image analysis and virtual reality. The company's stated mission is to become a leader in full-lifecycle solutions for functional eye disease — a category that includes amblyopia, strabismus, accommodative and binocular vision disorders, and the management of pediatric myopia progression.
That ambition is backed by a substantial intellectual property portfolio. Shijing Medical has filed for more than 200 intellectual property assets and holds more than 60 granted invention patents. The company has secured provincial-level key research and development project approvals, and it runs clinical trials and joint research programs with a number of well-known medical institutions in China. For international buyers, this matters for a practical reason: a digital therapeutic is only as credible as the clinical evidence and technical documentation behind it, and Shijing Medical has built its business around both.
DOBOSO: A Digital Diagnosis and Treatment Solution for Vision Function Training
The company's flagship platform is DOBOSO, a digital diagnosis and treatment solution for vision function training. DOBOSO is designed to support the assessment and rehabilitation of binocular and accommodative function through structured, software-guided training protocols delivered in virtual reality and screen-based formats.
Key characteristics that matter to distributors and clinic operators:
Software-first architecture. Training content, session parameters and progress records are managed digitally, which makes it easier for clinics to standardize protocols across multiple practitioners and locations.
Engagement by design. Pediatric rehabilitation fails when children disengage. DOBOSO uses immersive VR and interactive visual tasks to keep young patients involved across the full course of therapy — a factor clinicians repeatedly cite when recommending digital training over passive methods.
Deployment across care settings. The platform is used in hospitals, optometry centers and home-based therapy scenarios, allowing a clinician to supervise a treatment plan that continues between visits.
Proven installed base. DOBOSO and the company's related solutions are used in more than 3,000 eye hospitals and optometry centers across China, with cumulative users exceeding 500,000. The company reports that its market share in this product category has consistently remained a leader in the industry, and that the products have been well received by both clinicians and patients' parents.
BaBy Blissful: Photobiomodulation as a Digital Therapeutic
The second core solution is BaBy Blissful, a photobiomodulation (PBM) digital diagnosis and treatment solution. PBM applies specific light wavelengths to biological tissue to influence cellular function, and in eye care it is positioned as a non-invasive adjunctive approach within a structured treatment program. Shijing Medical's contribution is the digital layer: device control, treatment parameter management, session tracking and clinical workflow integration that turn a light-based intervention into a repeatable, auditable clinical service rather than a standalone hardware purchase.
Together, DOBOSO and BaBy Blissful give partners a two-track portfolio — functional vision training and photobiomodulation — that addresses different clinical needs while sharing the same philosophy of digitized, measurable care delivery.
Application Scenarios Across the Care Pathway
Hospital ophthalmology and pediatric eye departments use the platforms for in-clinic training sessions and for supervised rehabilitation programs that extend into the home. Optometry centers and vision care chains use them to build structured vision therapy service lines that differentiate their offering beyond refraction and eyewear. Home therapy programs allow families in regions with limited specialist access to continue treatment under remote clinical guidance. Because the products are software-centered, the same core protocols can be adapted to different service models without rebuilding the clinical content.
Standards Work and Industry Research
A company's willingness to invest in standards and published research is a useful signal of long-term intent. Shijing Medical has led or participated in the drafting of multiple team and industry standards, including technical and application specifications for VR-based visual training systems. The company has also co-published major industry reports with Frost & Sullivan and MedSci, including a blue book on the current status and future trends of myopia management for children and adolescents (2026 edition), a blue book on the digital treatment landscape for pediatric amblyopia and strabismus in China, and a related white paper on the same clinical area. For overseas partners, these materials provide a structured view of how digital vision therapy is being practiced and measured in one of the world's largest eye care markets.
Recognition and Market Position
Shijing Medical has been named to Guangzhou's list of top 100 high-tech enterprises in the pre-listing pipeline, selected for the Deloitte China Rising Star program, and recognized among China's Top 10 Digital Therapeutics companies. It has also received a Global Ophthalmology Clinical Application Award and recognition as a leading brand in Chinese visual function training. These distinctions reflect both clinical adoption and commercial traction in the company's home market.
Why International Partners Should Take a Closer Look
Digital therapeutics for eye care are moving from novelty to standard practice, and the markets that adopt them earliest will set the clinical protocols others follow. Shijing Medical offers international distributors, clinic groups and eye care chains a partner with eighteen years of focused development in ophthalmology and optometry, a protected technology base, an installed footprint of more than 3,000 clinical sites, and a portfolio that spans both vision function training and photobiomodulation. The company is open to discussing distribution partnerships, clinical collaboration and market-entry arrangements with qualified organizations.
Contact Shijing Medical
To discuss product information, distribution opportunities or clinical collaboration, please reach out directly:
Website: www.shijingmed.com
Email: fangtao@topeye.cn
Phone: +86 4008777511 / +86 15021168718
WeChat: yesmylord123
Share your market, your target clinical setting and the patient populations you serve, and the Shijing Medical team can outline how DOBOSO and BaBy Blissful could fit into your portfolio. Serious enquiries are welcome — the earlier the conversation starts, the sooner your team can evaluate a partnership built on eighteen years of ophthalmic technology development.